CClinicalTrials.gg
WithdrawnNCT00530751Updated Oct 2, 2015

Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation

An observational study in Breast Cancer, sponsored by Case Comprehensive Cancer Center. Withdrawn at 7 sites in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-10-02.

Sponsored by Case Comprehensive Cancer Center · Observational

Why this study was withdrawn
PI left
Study type
Observational
Model
Family-based
Time perspective
Prospective
Enrollment
0
Ages
18 Years and older
Sex
Female
01

Study summary

RATIONALE: Learning about the concerns that individuals may have about providing family medical history online for genetic risk assessment or research may help doctors plan future research.

PURPOSE: This clinical trial is studying views on sharing family medical history in healthy women undergoing mammograms or breast evaluation.

Read the detailed description

OBJECTIVES:

  • To gain an initial understanding of the ethical, family, and related concerns that individuals may have when offered the option of providing family medical history online for genetic risk assessment or research.
  • To identify specific directions for future research into the ethics of online genetic risk assessment.

OUTLINE: Participants undergo a 45-60 minute interview to assess their attitudes and concerns about providing family medical history online for genetic risk assessment or research. Participants' feelings about whether or not to use an online genetic assessment tool (i.e., Genetic Risk Easy Assessment Tool [GREAT]) are explored. The GREAT allows for the electronic creation, analysis, and dissemination of family histories of individuals who may be at risk for various types of cancer. Key factors influencing a participant's use of the tool, including concerns about confidentiality, privacy, informed consent, access to risk information, and security of online family history databases, are explored. Ethical issues regarding communication and agreement among family members on disclosing family medical history are also discussed.

02

Conditions studied

  • Breast Cancer

Browse trials for

Keywords

  • breast cancer
03

In context

Breast Neoplasms

12,543 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

Browse Breast Neoplasms studies →

Lead sponsor

Case Comprehensive Cancer Center is the lead sponsor of 484 studies on the registry; 59 are open to participants now.

Of its 74 completed or terminated interventional studies of FDA-regulated products, 45 (61%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Primary care center

Eligibility criteria

DISEASE CHARACTERISTICS:

  • Healthy women undergoing mammograms or being evaluated for a breast concern at the University Hospitals Breast Center

PATIENT CHARACTERISTICS:

  • Able to speak English

PRIOR CONCURRENT THERAPY:

  • Not specified
05

Study design

Observational model
Family-based
Time perspective
Prospective
Enrollment
0 participants (actual)

Interventions

  • Othercounseling intervention

    Participants undergo a 45-60 minute interview to assess their attitudes and concerns about providing family medical history online for genetic risk assessment or research. Participants' feelings about whether or not to use an online genetic assessment tool (i.e., Genetic Risk Easy Assessment Tool \[GREAT\]) are explored.

06

What researchers measure

Primary outcomes

  1. Participants' perspectives and concerns regarding online genetic risk assessment or research

  2. Identification of directions for future research into the ethics of online genetic risk assessment or research

07

Study locations

7 sites
  • Mercy Cancer Center at Mercy Medical Center
    Canton, Ohio 44708, United States
  • Geauga Regional Hospital
    Chardonr, Ohio 44024, United States
  • Lake/University Ireland Cancer Center
    Mentor, Ohio 44060, United States
  • Southwest General Health Center
    Middleburgh Heights, Ohio 44130, United States
  • UHHS Chagrin Highlands Medical Center
    Orange Villager, Ohio 44122, United States
  • University Suburban Health Center
    South Euclid, Ohio 44121, United States
  • UHHS Westlake Medical Center
    Westlaker, Ohio 44145, United States
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 2, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00530751
Lead sponsor
Case Comprehensive Cancer Center
Collaborators
National Cancer Institute (NCI)
First posted
Sep 17, 2007
Start date
Mar 2007
Primary completion
Oct 2008
Last update
Oct 2, 2015

Study contacts

Christian Simon, PhD
study chair · Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Oct 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion